In 2023, Germany and Belgium were the leading exporters of hygienic or pharmaceutical rubber articles in Europe, accounting for 44.17% and 38.99% of the market share by weight, respectively. However, Germany's share grew by 3.19%, while Belgium's declined by 5.42%. France and Italy also saw reductions of 5.14% and a dramatic 100.0%, respectively. Significant growth was observed in countries like Ireland (32.46%), Estonia (32.91%), Lithuania (41.28%), and Greece (31.53%). In contrast, the United Kingdom and Denmark completely exited the market with a 100.0% decline. Overall, smaller nations like Latvia, Finland, and Romania demonstrated modest increases, reflecting a shift toward diversifying sources.
Future trends suggest a continued dominance by Germany as a central hub, with smaller but notable contributions from countries like Ireland, Estonia, and Lithuania, potentially fostered by technological advancements and strategic trade policies. Watch for changes in EU regulatory environments and investment in production capabilities, which could further impact export dynamics. Monitoring new entrants and technological innovations in the industry will be key to anticipating shifts in market share.
Top countries in Export of Hygienic or Pharmaceutical Articles of Rubber (Excluding Sheath Contraceptives) Share by Country (Kilograms)
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 44.17 | 2023 | +1.73% | +3.19% | View data |
| 2 | 2 Belgium | 38.99 | 2023 | +21.99% | -5.42% | View data |
| 3 | 3 France | 8.78 | 2023 | -4.59% | -5.14% | View data |
| 4 | 4 Italy | 5.83 | 2023 | View data | ||
| 5 | 5 Netherlands | 2.02 | 2021 | -5.31% | +12.49% | View data |
| 6 | 6 Spain | 1.85 | 2023 | -3.86% | +4.31% | View data |
| 7 | 7 Slovakia | 1.57 | 2023 | +4.02% | +2.64% | View data |
| 8 | 8 Sweden | 0.54 | 2023 | +4.74% | -0.75% | View data |
| 9 | 9 Romania | 0.47 | 2023 | +4.68% | +6.63% | View data |
| 10 | 10 Poland | 0.46 | 2023 | -6.46% | +2.97% | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...